InvestorsHub Logo
Followers 71
Posts 7941
Boards Moderated 0
Alias Born 01/29/2015

Re: Carthnel post# 27275

Thursday, 04/21/2022 2:17:56 PM

Thursday, April 21, 2022 2:17:56 PM

Post# of 27520
You're making up your own conclusions about the 50/50 FAIMS tech. I've consistently said I believe the FAIMS is inferior to the competition. A reason why it remains in a prototype status indefinitely. The point of the 50/50 issue is the tech was pulled out from under shareholders at Algernon. It happened around the same time Algernon's CEO (Christopher Moreau) and CSO (Mark Williams, PhD, MBA) was on the payroll at now failed - First Responder Technologies. Yeah, Algernon's top management was beholden to the whims of Cannabix's "President" and Director because Kulwant Mahli was the Chairman of the Board at First Responder Technologies around such time. I believe it was the same year the CEO of Algernon put together a compensation package for himself north of 1 million dollars. Imagine that...a Million dollar CEO of a pennyland nano cap company with a market cap of 7 Million dollars just surrendering the FAIMS technology for not a single done or shared of Cannabix for it's years long collaboration. Moreau has learned the type of bad faith habits that should get anyone Fired, Fined, and/or Perp Walked. So, no to the performance of the FAIMS technology because it all remains mystery meat. You don't really have a clue about what you supposedly own from a working breathalyzer perspective. Cannabix will be dilly dallying around with something else shiny and new to you in the coming months and years. Don't get tied up in knots because I speak the truth of the matters. Attacking me does nothing for your cause - a lost cause IMO. Stories is what Cannabix and Algernon offer year after year to shareholders. Thus, I'm telling their story.



2077 is the year of Cannabix's time to shine.

M$
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BLOZF News